Skip to main content


Swipe om te navigeren naar een ander artikel

01-12-2009 | Commentary | Uitgave 1/2009 Open Access

Journal of Foot and Ankle Research 1/2009

Recent developments in podiatric prescribing in the UK and Australia

Journal of Foot and Ankle Research > Uitgave 1/2009
Mark F Gilheany, Alan M Borthwick
Belangrijke opmerkingen

Competing interests

One author (AMB) is currently Deputy Editor (UK) of the Journal of Foot and Ankle Research, and first author of a paper referred to directly in this commentary.

Authors' contributions

Both authors were equally involved in the design and writing of the paper. AMB initially drafted the overall context and the UK element of the manuscript, and MFG drafted the Australian context, with additions to the context. Critical revision was undertaken by both authors. Both authors contributed to the interpretation offered.


Recent and substantial changes in access to restricted medicines by podiatrists in Australia are clearly consistent with healthcare policies aimed at reshaping the healthcare workforce. At the same time, prescribing and access to medicines by allied health professionals, including podiatrists, has been the focus of a recent scoping project by the UK Department of Health. In this commentary we explore the possible implications of these changes.

Onze productaanbevelingen

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Over dit artikel

Andere artikelen Uitgave 1/2009

Journal of Foot and Ankle Research 1/2009 Naar de uitgave